21 May 2013
Keywords: alizyme, details, strategy, pipeline, uk, firm, focuses
Article | 18 November 1996
UK firm Alizyme, which focuses on developing new drugs for obesity and
gastrointestinal disorders, has given an update on the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 November 1996
25 November 1996
© 2013 thepharmaletter.com